USPTO trademark

Tarsus Pharmaceuticals, Inc design mark 50158061

Under examinationUSPTOFigurative markClass 5

"Design mark 50158061" is a figurative mark owned by Tarsus Pharmaceuticals, Inc., filed at the USPTO on October 13, 2026. It is under examination and covers class 5 (Pharmaceuticals).

View Tarsus Pharmaceuticals, Inc. portfolioGet this data via the API
Official USPTO record
Tarsus Pharmaceuticals, Inc design mark 50158061 trademark as filed
As filed with the USPTO
Status
Under examination
Since October 13, 2026
Filed
October 13, 2026
Registered
Not yet
Expires
Not recorded
Application no.
50158061
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Figurative mark
1 class
Ownership

Who owns Tarsus Pharmaceuticals, Inc design mark 50158061

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Tarsus Pharmaceuticals, Inc.

TARS · Irvine, United States

45 trademarks in the portfolioView company

Representative

Catherine Holland

Knobbe, Martens, Olson & Bear, LLP

Goods and services

What the mark covers

The products and services Tarsus Pharmaceuticals, Inc design mark 50158061 is filed for, grouped by Nice class.

  • Ophthalmic preparations; Preparations for destroying parasites; Pharmaceutical preparations for the treatment of Demodex blepharitis; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Eye drops; Pharmaceutical preparations for the treatment of eye diseases and conditions

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Application filing receipt mailed
  2. Application filing receipt mailed
  3. New application entered
FAQ

About Tarsus Pharmaceuticals, Inc design mark 50158061

Who owns the trademark "Design mark 50158061"?

The USPTO trademark "Design mark 50158061" (application 50158061) is owned by Tarsus Pharmaceuticals, Inc.

What is the status of "Design mark 50158061"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull Tarsus Pharmaceuticals, Inc design mark 50158061 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a13a85-e0d7-71ea-ae1a-d2a837596ec9
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a13a85-e0d7-71ea-ae1a-d2a837596ec9",
  "object": "trademark",
  "mark_text": "[Design Mark]",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "50158061",
  "filing_date": "2026-10-13",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Tarsus Pharmaceuticals, Inc.",
      "entity_id": "ent_019ebbd7-2585-716e-99ec-5f7ae3754100"
    }
  ]
}